LNX1-AS1
gene geneOn this page
Summary
LNX1-AS1 (LNX1 antisense RNA 1, HGNC:40345) is a long non-coding RNA gene on chromosome 4q12.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:40345 |
| Approved symbol | LNX1-AS1 |
| Name | LNX1 antisense RNA 1 |
| Location | 4q12 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000250930 |
| Ensembl biotype | lncRNA |
| Entrez | 100873939 |
| RNAcentral | URS000075DCAF — lncRNA, 564 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 lncRNA
ENST00000502373, ENST00000510785, ENST00000511989, ENST00000514364, ENST00000815256, ENST00000815257, ENST00000815258, ENST00000815259, ENST00000815260
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000502373 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002037070 | 53496400 | 53496599 |
| ENSE00002058302 | 53500417 | 53500502 |
Expression profiles
Bgee: expression breadth ubiquitous, 108 present calls, max score 94.18.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0074 / max 9.4728, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 47626 | 0.0074 | 3 |
Top tissues by expression
108 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 94.18 | gold quality |
| left testis | UBERON:0004533 | 84.04 | gold quality |
| testis | UBERON:0000473 | 83.30 | gold quality |
| right testis | UBERON:0004534 | 82.69 | gold quality |
| colonic epithelium | UBERON:0000397 | 80.39 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 69.87 | gold quality |
| tonsil | UBERON:0002372 | 69.51 | gold quality |
| corpus callosum | UBERON:0002336 | 68.67 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 68.38 | gold quality |
| sural nerve | UBERON:0015488 | 67.80 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 65.01 | gold quality |
| primary visual cortex | UBERON:0002436 | 62.52 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 61.86 | gold quality |
| uterine cervix | UBERON:0000002 | 60.56 | gold quality |
| calcaneal tendon | UBERON:0003701 | 59.65 | gold quality |
| endocervix | UBERON:0000458 | 58.21 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 58.09 | gold quality |
| prefrontal cortex | UBERON:0000451 | 56.91 | gold quality |
| kidney | UBERON:0002113 | 56.78 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 56.54 | gold quality |
| right adrenal gland | UBERON:0001233 | 56.08 | gold quality |
| islet of Langerhans | UBERON:0000006 | 55.79 | gold quality |
| placenta | UBERON:0001987 | 55.68 | gold quality |
| liver | UBERON:0002107 | 55.47 | gold quality |
| skin of leg | UBERON:0001511 | 55.37 | gold quality |
| monocyte | CL:0000576 | 55.36 | gold quality |
| esophagus mucosa | UBERON:0002469 | 55.24 | gold quality |
| esophagus | UBERON:0001043 | 54.12 | gold quality |
| zone of skin | UBERON:0000014 | 54.07 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 53.88 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.82 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.